ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES

Bente Glintborg; U Lindstrom; D Di Giuseppe; SA Provan; B Gudbjornsson; Merete Lund Hetland; B Michelsen; JK Wallman; K Aaltonen; AM Hokkanen; TS Jorgensen; RL Hansen; AJ Geirsson; Kathrine Lederballe Grøn; NS Krogh; J Askling; LE Kristensen; LTH Jacobsson

ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES

Bente Glintborg, U Lindstrom, D Di Giuseppe, SA Provan, B Gudbjornsson, Merete Lund Hetland, B Michelsen, JK Wallman, K Aaltonen, AM Hokkanen, TS Jorgensen, RL Hansen, AJ Geirsson, Kathrine Lederballe Grøn, NS Krogh, J Askling, LE Kristensen, LTH Jacobsson

Department for Rheumatology and Spine Diseases

Original language	Danish
Article number	FRI0275
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	Suppl. 1
Pages (from-to)	724-725
Number of pages	2
ISSN	0003-4967
Publication status	Published - 2020

Cite this

Glintborg, B., Lindstrom, U., Di Giuseppe, D., Provan, SA., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Wallman, JK., Aaltonen, K., Hokkanen, AM., Jorgensen, TS., Hansen, RL., Geirsson, AJ., Grøn, K. L., Krogh, NS., Askling, J., Kristensen, LE., & Jacobsson, LTH. (2020). ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES. Annals of the Rheumatic Diseases, 79(Suppl. 1), 724-725. Article FRI0275.

ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES. / Glintborg, Bente; Lindstrom, U; Di Giuseppe, D et al.
In: Annals of the Rheumatic Diseases, Vol. 79, No. Suppl. 1, FRI0275, 2020, p. 724-725.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B, Lindstrom, U, Di Giuseppe, D, Provan, SA, Gudbjornsson, B, Hetland, ML, Michelsen, B, Wallman, JK, Aaltonen, K, Hokkanen, AM, Jorgensen, TS, Hansen, RL, Geirsson, AJ, Grøn, KL, Krogh, NS, Askling, J, Kristensen, LE & Jacobsson, LTH 2020, 'ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, FRI0275, pp. 724-725.

@article{4acf1799b02e4935bdda65fbfa23f3cb,

title = "ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES",

author = "Bente Glintborg and U Lindstrom and \{Di Giuseppe\}, D and SA Provan and B Gudbjornsson and Hetland, \{Merete Lund\} and B Michelsen and JK Wallman and K Aaltonen and AM Hokkanen and TS Jorgensen and RL Hansen and AJ Geirsson and Gr{\o}n, \{Kathrine Lederballe\} and NS Krogh and J Askling and LE Kristensen and LTH Jacobsson",

note = "COPECARE",

year = "2020",

language = "Dansk",

volume = "79",

pages = "724--725",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "Suppl. 1",

}

TY - ABST

T1 - ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES

AU - Glintborg, Bente

AU - Lindstrom, U

AU - Di Giuseppe, D

AU - Provan, SA

AU - Gudbjornsson, B

AU - Hetland, Merete Lund

AU - Michelsen, B

AU - Wallman, JK

AU - Aaltonen, K

AU - Hokkanen, AM

AU - Jorgensen, TS

AU - Hansen, RL

AU - Geirsson, AJ

AU - Grøn, Kathrine Lederballe

AU - Krogh, NS

AU - Askling, J

AU - Kristensen, LE

AU - Jacobsson, LTH

N1 - COPECARE

PY - 2020

Y1 - 2020

M3 - Konferenceabstrakt i tidsskrift

SN - 0003-4967

VL - 79

SP - 724

EP - 725

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - FRI0275

ER -